Literature DB >> 2780052

Expression of the K-fgf protooncogene is repressed during differentiation of F9 cells.

A Velcich1, P Delli-Bovi, A Mansukhani, E B Ziff, C Basilico.   

Abstract

Utilizing F9 embryonal carcinoma cells as a model system for early mammalian development, we have studied the pattern of expression of the endogenous murine homolog of the human K-fgf/hst oncogene, which encodes a new member of the fibroblast growth factors (FGFs) family. The K-fgf mRNA is expressed in undifferentiated F9 cells and its level becomes undetectable upon the induction of differentiation. Furthermore, a growth-promoting activity with properties identical to those of K-FGF is present in the conditioned medium of F9 cells, but absent in that of differentiated cells. Shut-off of K-fgf expression is mediated at the transcriptional level. The acidic FGF gene is also expressed in undifferentiated F9 cells and down modulated once differentiation is induced. In contrast, int-2, another member of the FGF gene family, is transcriptionally induced in differentiated F9 cells. Our data suggest that single members of the FGF gene family may perform distinct functions in vivo, and that the physiological role of K-FGF may be related to early development.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2780052

Source DB:  PubMed          Journal:  Oncogene Res        ISSN: 0890-6467


  14 in total

Review 1.  Angiogenesis and angiogenesis inhibitors in paediatric diseases.

Authors:  L Schweigerer; T Fotsis
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

2.  Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites.

Authors:  D C Ambrosetti; C Basilico; L Dailey
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

3.  NF-Y behaves as a bifunctional transcription factor that can stimulate or repress the FGF-4 promoter in an enhancer-dependent manner.

Authors:  Cory T Bernadt; Tamara Nowling; Matthew S Wiebe; Angie Rizzino
Journal:  Gene Expr       Date:  2005

4.  Characterization of fibroblast growth factor activity secreted by embryonal carcinoma cells.

Authors:  K Miller; A Rizzino
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-10       Impact factor: 2.416

5.  Fibroblast growth factor complexed to the cytotoxin saporin is growth inhibitory but not cytotoxic for embryonal carcinoma cells.

Authors:  K Miller; P J Wilder; A Rizzino
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

6.  NF-kappa B-independent activation of beta-interferon expression in mouse F9 embryonal carcinoma cells.

Authors:  M J Ellis; S Goodbourn
Journal:  Nucleic Acids Res       Date:  1994-10-25       Impact factor: 16.971

7.  Expression of the K-fgf proto-oncogene is controlled by 3' regulatory elements which are specific for embryonal carcinoma cells.

Authors:  A M Curatola; C Basilico
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

8.  Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer.

Authors:  L Dailey; H Yuan; C Basilico
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

9.  Expression of fibroblast growth factor receptors by embryonal carcinoma cells and early mouse embryos.

Authors:  W J Campbell; K A Miller; T M Anderson; J D Shull; A Rizzino
Journal:  In Vitro Cell Dev Biol       Date:  1992-01

10.  Heparin-binding secretory transforming gene (hst) facilitates rat lactotrope cell tumorigenesis and induces prolactin gene transcription.

Authors:  I Shimon; A Hüttner; J Said; O M Spirina; S Melmed
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.